Factors associated with injection omission/non-adherence in the global attitudes of patients and physicians in insulin therapy study

Diabetes, Obesity and Metabolism

Volumn 14, Issue 12, 2012, Pages 1081-1087

  Peyrot, Mark ^a   Barnett, A H ^b   Meneghini, L F ^c   Schumm Draeger, P M ^d  

^a LOYOLA UNIVERSITY MARYLAND   (United States)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d KLINIKUM BOGENHAUSEN   (Germany)

Author keywords

Diabetes mellitus; Drug compliance; Drug utilization; Insulin therapy; Observational study

Indexed keywords

INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; RISK FACTOR; SELF REPORT; TELECONSULTATION; TREATMENT DURATION; ATTITUDE TO HEALTH; CHINA; CLINICAL TRIAL; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; ETHNOLOGY; FRANCE; GERMANY; GLUCOSE BLOOD LEVEL; HEALTH BEHAVIOR; HEALTH PERSONNEL ATTITUDE; JAPAN; MEDICATION COMPLIANCE; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGY; RISK REDUCTION; SPAIN; TURKEY; UNITED KINGDOM; CROSS-SECTIONAL STUDY; DRUG DOSE REGIMEN; HEALTH BELIEF; INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; SOCIAL PSYCHOLOGY; TELEPHONE INTERVIEW; TURKEY (REPUBLIC); UNITED STATES;

ADULT; ATTITUDE OF HEALTH PERSONNEL; BLOOD GLUCOSE; CHINA; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FRANCE; GERMANY; GREAT BRITAIN; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; JAPAN; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RISK FACTORS; RISK REDUCTION BEHAVIOR; SPAIN; TURKEY;

EID: 84870420284     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2012.01636.x     Document Type: Article

References (22)

1. Cramer JA, Pugh MJ. The influence of insulin use on glycemic control: how well do adults follow prescriptions for insulin? Diabetes Care 2005; 28: 78-83.
2. Morris AD, Boyle DIR, McMahon D, MacDonald TM, Newton RW, for the DRTS/MEMO Collaboration. Adherence to insulin treatment, glycemic control, and ketoacidosis in insulin-dependent diabetes mellitus. Lancet 1997; 350: 1505-1510.
3. Schober E, Wagner G, Berger G et al., on behalf of the Austrian Diabetic Incidence Study Group. Prevalence of intentional under- and overdosing of insulin in children and adolescents with type 1 diabetes. Pediatr Diabetes 2011; 12: 627-631.
4. Olinder AL, Kernell A, Smide B. Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetes. Pediatr Diabetes 2009; 10: 142-148.
5. Polonsky WH, Anderson BJ, Lohrer PA, Aponte JE, Jacobson AM, Cole CF. Insulin omission in women with IDDM. Diabetes Care 1994; 17: 1178-1185.
6. Broadbent E, Donkin L, Stroh JC. Illness and treatment perceptions are associated with adherence to medications, diet, and exercise in diabetic patients. Diabetes Care 2011; 34: 338-340.
7. Donnelly LA, Morris AD, Evans JM, DARTS/MEMO collaboration. Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM 2007; 100: 345-350.
8. Takii M, Uchigata Y, Tokunaga S et al. The duration of severe insulin omission is the factor most closely associated with the microvascular complications of Type 1 diabetic females with clinical eating disorders. Int J Eat Disord 2008; 41: 259-264.
9. Randløv J, Poulsen JU. How much do forgotten insulin injections matter to hemoglobin a1c in people with diabetes? A simulation study. J Diabetes Sci Technol 2008; 2: 229-235.
10. Peyrot M, Rubin RR, Kruger D, Travis L. Correlates of insulin injection omission. Diabetes Care 2010; 33: 243-248.
11. Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 2006; 28: 1712-1725.
12. Di Battista AM, Hart TA, Greco L, Gloizer J. Type 1 diabetes among adolescents: reduced diabetes self-care caused by social fear and fear of hypoglycemia. Diabetes Educ 2009; 35: 465-475.
13. Peyrot M, Skovlund SE, Landgraf R. Epidemiology and correlates of weight worry in the multi-national Diabetes Attitudes, Wishes and Needs (DAWN) Study. Curr Med Res Opin 2009; 25: 1985-1993.
14. Peyrot M, Barnett AH, Meneghini LF, Schumm-Draeger P. Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study. Diabet Med 2012; 29: 682-689.
15. Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care 1987; 10: 617-621.
16. Fritsche A, Stefan N, Håring H, Gerich J, Stumvoll M. Avoidance of hypoglycemia restores hypoglycemia awareness by increasing betaadrenergic sensitivity in type 1 diabetes. Ann Intern Med 2001; 134: 729-736.
17. Leiter LA, Yaly J, Chiasson J, Harris SB, Kleinstiver P, Sauriol L. Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management. Can J Diabetes 2005; 29: 186-192.
18. Peyrot M, McMurry JF, Kruger DF. A biopsychosocial model of glycemic control in diabetes: stress, coping and regimen adherence. J Health Soc Behav 1999; 40: 141-158.
19. Peyrot M, Rubin RR. Behavioral and psychosocial interventions in diabetes: a conceptual review. Diabetes Care 2007; 30: 2433-2440.
20. Rubin RR, Peyrot M, Kruger DF, Travis LB. Barriers to insulin injection therapy: patient and health care provider perspectives. Diabetes Educ 2009; 35: 1014-1022.
21. Rubin RR. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med 2005; 118(Suppl 5): 27S-34S.
22. Wagner TH, Heisler M, Piette JD. Prescription drug co-payments and cost-related medication underuse. Health Econ Policy Law 2008; 3: 51-67.